Mariacarla Valli

ORCID: 0000-0002-7880-4645
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Breast Cancer Treatment Studies
  • Advanced Radiotherapy Techniques
  • Breast Lesions and Carcinomas
  • Advances in Oncology and Radiotherapy
  • Global Cancer Incidence and Screening
  • Radiomics and Machine Learning in Medical Imaging
  • Head and Neck Cancer Studies
  • Brain Metastases and Treatment
  • Effects of Radiation Exposure
  • Lung Cancer Treatments and Mutations
  • Cancer Treatment and Pharmacology
  • Lung Cancer Diagnosis and Treatment
  • Advanced Breast Cancer Therapies
  • Nonmelanoma Skin Cancer Studies
  • Endometrial and Cervical Cancer Treatments
  • Cervical Cancer and HPV Research
  • Radiation Therapy and Dosimetry
  • Genetic factors in colorectal cancer
  • Sarcoma Diagnosis and Treatment
  • Medical Imaging Techniques and Applications
  • Cancer Diagnosis and Treatment
  • Cancer Genomics and Diagnostics
  • Chemotherapy-induced cardiotoxicity and mitigation
  • Glioma Diagnosis and Treatment
  • Cardiac Imaging and Diagnostics

Ente Ospedaliero Cantonale
2022-2025

Ospedale Sant'Anna
2015-2024

Institute of Oncology Research
2010-2023

European Organisation for Research and Treatment of Cancer
2022

Ospedale Regionale di Bellinzona e Valli
2015-2019

Università della Svizzera italiana
2018

European Organisation for Research and Treatment of Cancer
2014

Ospedale Santa Chiara
2000

The effect of internal mammary and medial supraclavicular lymph-node irradiation (regional nodal irradiation) added to whole-breast or thoracic-wall after surgery on survival among women with early-stage breast cancer is unknown.We randomly assigned who had a centrally medially located primary tumor, irrespective axillary involvement, an externally tumor involvement undergo either in addition regional (nodal-irradiation group) alone (control group). end point was overall survival. Secondary...

10.1056/nejmoa1415369 article EN New England Journal of Medicine 2015-07-22

The results in terms of side effects vary among the published accelerated partial-breast irradiation (APBI) studies. Here, we report 5-year for cosmetic outcomes and toxicity IRMA trial.We ran this randomized phase III trial 35 centers. Women with stage I-IIA breast cancer treated breast-conserving surgery, age ≥ 49 years, were randomly assigned 1:1 to receive either whole-breast (WBI) or external beam radiation therapy APBI (38.5 Gy/10 fraction twice daily). Patients investigators not...

10.1200/jco.22.01485 article EN Journal of Clinical Oncology 2023-01-09

Uncertainty about the benefit-risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) improve shared decision making.The multicenter European Organization for Research Treatment Cancer trial (ClinicalTrials.gov, NCT00002851) randomly assigned stage I-III breast cancer patients with involved axillary nodes and/or a medially located primary tumor. analyzed both...

10.1093/jnci/djab113 article EN JNCI Journal of the National Cancer Institute 2021-06-04

Abstract Background To report about initial clinical experience in radiation treatment of carcinoma prostate with volumetric modulated arcs the RapidArc (RA) technology. Methods Forty-five patients a median age 72 ± 3, affected by (T1c: 22 patients, T2a-b: 17 T3a-b: 6 patients. N0: 43 N1-Nx: 2 all M0), PSA 10.0 3.0 ng/mL, were treated feasibility study. All single arc using 6MV photons. Dose prescription ranged between 76 (7 patients) and 78 Gy (38 2Gy/fraction. Plan quality was assessed...

10.1186/1748-717x-5-54 article EN cc-by Radiation Oncology 2010-06-16

Circulating tumor DNA (ctDNA) correlates with the response to therapy in different types of cancer. However, patients locally advanced rectal cancer (LARC), little is known about how ctDNA levels change neoadjuvant chemoradiation (Na-ChRT) and they correlate treatment response. This work aimed explore value serial liquid biopsies monitoring after Na-ChRT hypothesis that this could become a reliable biomarker identify complete response, candidates for non-operative management.Twenty-five...

10.3389/fonc.2022.900945 article EN cc-by Frontiers in Oncology 2022-06-28

The aim of our study is to determine whether deep inspiration breath hold (DIBH) effective for reducing exposure the heart, left coronary artery (LAD) and both lungs in right breast radiotherapy.We have analyzed 10 consecutive patients with right-sided cancer (BC), simulated during free breathing (FB) DIBH modality. For all we contoured PTV organs at risk (right lungs, LAD) on CT scans (FB DIBH). Finally, 5 were treated IMRT VMAT techniques.All able end treatments modalities regardless...

10.5603/rpor.a2022.0085 article EN cc-by-nc-nd Reports of Practical Oncology & Radiotherapy 2022-09-19
Nicholas Pavlidis Radosław Mądry Marc Peeters Sergio Sandrucci Janina Markowska and 91 more Fedro A. Peccatori Alberto Costa Jesper Grau Eriksen Umberto Ricardi Richard Poetter D. Schrijvers Jan B. Vermorken Mario Airoldi Marco E. Allaix Suleyman Altinta Sébastien Anguille A.D. Baildam Marcella Baldewijns Halina Batura‐Gabryel Alessandra Beano Bettina Blaumeiser Gerben Borst Alessandro Camandone Guido Casalis Cavalchini Szczepan Cofta Jacques De Grève Wim Demey Katarzyna Derwich Ann Driessen Riccardo Faletti Hans‐Henning Flechtner Kevin Francis Sofie Goethals Wojciech Golunski Marjan Hertoghs Lucien Hoekx Ann Janssens A. Karczewska-Dzionk Agnieszka Kołacińska Mieczyslaw Komarnciki Niels Komen Joanna Kufel-Grabowska Paweł Kurzawa Witold Kycler Paolo Leombruni Willen Lybaert Marcin Mardas Paul Meijnders Franco Merletti T.J.M. Mertens Piotr Milecki Jezry Moczko Mario Morino Dawid Murawa Daan Nevens Koenzaad Norga Jonathan A. Nowak Paulina Nowak M. Oderda Bart Op de Beeck Konstantinos I. Papadimitriou Paul M. Parizel Piotr Pieńkowski Grzegorz Poprawski Marta I. Porębiak Patrizia Racca Katarzyna Rajewska Marlene Rasschaert Christian Rolfo O. Sedigh E. Senkus-Konefka Evelien Smits Pol Specenier Maarten Spinhoven Joanna Stanisławiak‐Rudowicz Monika Szarszewska Wiebren Tjalma Piotr Tomczak Becky Trinh Stefano Vallero Mariacarla Valli Guy Van Camp Peter A. van Dam Jan Van der Brande Marieka Vandewiele Guido Van Hal Carl Van Laer Paul Van Schil Viggo Vantendeloo Lies Verheuen Joris Verlooy Umberto Vitolo Jacek Wachowlak Sofie Wouters Dirk Ysebaert Paolo Zola

10.1007/s13187-020-01947-3 article EN Journal of Cancer Education 2021-01-02

Aim. The purpose of this planning report is to compare dosimetric results deep inspiration breath hold (DIBH) and free breathing (FB) set up in patients with synchronous bilateral breast cancer (SBBC) treated adjuvant radiotherapy. Material methods. Fourteen early stage were conservative surgery. Bilateral treatment volume (PTV) organs at risk (OARs) delineated for DIBH FB datasets on the computed tomography (CT). Volumetric modulated arc therapy (VMAT/RapidArc ®) plans generated two...

10.1088/2057-1976/aac19b article EN Biomedical Physics & Engineering Express 2018-05-01

10.1007/s40336-016-0202-y article EN Clinical and Translational Imaging 2016-08-02

To analyze the impact of adjuvant radiotherapy (RT) on ipsilateral breast recurrence (IBR) and overall survival (OS) in patients older than 69 years with early-stage cancer.From January 2007 to June 2015, we analyzed retrospectively 137 women estrogen receptor-positive T1-2 invasive cancer, negative axillary lymph nodes, dividing them into 2 subgroups: 70 79 years.After a median follow-up 43.2 months, 3-year IBR-free treated surgery plus RT was 98.8% 92.1% alone, significant difference (p =...

10.1177/0300891618792465 article EN Tumori Journal 2018-08-27

The incidence of breast cancer is rising worldwide. Recent advances in systemic and local treatments have significantly improved survival rates patients having early cancer. In the last decade, great attention has been paid to prevention detection cardiotoxicity induced by treatments. Systemic therapy-related cardiac toxicities extensively studied. Radiotherapy, an essential component treatment, can also increase risk heart diseases. Consequently, it important balance expected benefits...

10.2196/31887 article EN cc-by JMIR Research Protocols 2021-11-27
Coming Soon ...